Bionano Genomics

BNGONasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$15.522 M

$1.11 -6.70%

Close of 6 Nov 2026

As of 6 Nov 2026, Bionano Genomics (BNGO) has a market capitalization of $15.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$28.5M

#2871 by revenue

Earnings

-$26.4M

Loss-making

Shares outstanding

11,777,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#18Rapid Micro BiosystemsRPID$31.2M
#19EyePointEYPT$31.1M
#20Circle8 GroupCIRC$23.8M
#21Bionano GenomicsBNGO$15.5M
#22AstrotechASTC$8.39M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Bionano Genomics, worth $4.86K. Grants and option exercises are excluded.

Albert LudererInterim Chief Executive$4.86K
4,000 shares at $1.22 on 21 Aug 2026 · filed 21 Aug 2026

What if Bionano Genomics were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,019,865

Per share 1,819,207× higher

Bitcoin $1.53T

$109,291.38

Per share 98,434× higher

Apple $5.02T

$358,793.41

Per share 323,150× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Bionano Genomics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.